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REPLY
The letter by Dr. Erdogan made some good points that, although
in our view do not detract from the results and conclusions of our
study, are of general interest to the issue of defibrillation success.
We appreciate the opportunity to clarify the purpose of our study,
which may have eluded some other readers as well.
Most patients in our study were free from antiarrhythmic drugs
for five half-lives, except for two patients who had received prior
amiodarone therapy that failed to suppress the targeted arrhyth-
mia. Though we do not necessarily subscribe to the value of the
12-lead electrocardiogram as a means to demonstrate the disper-
sion of repolarization at the myocardial level (1,2), it is quite
possible, as Dr. Erdogan states in his letter, that residual amioda-
rone and other factors such as anesthesia, electrolytes, autonomic
tone, etc., may have influenced the dispersion of repolarization in
our patients. Any of these influences might enter into the equation
that governs the probabilistic nature of the defibrillation threshold
(DFT), and that of the fibrillation threshold as well. However, it
was not the purpose of our study to discern the effects of such
factors on the DFT or ventricular fibrillation (VF) inducibility by
ICD shocks.
Instead, our purpose was to show that, in a single patient and at
a given time, the probability of inducibility of VF by a T-wave
shock and the failure to terminate VF by a second shock were
strongly associated with the extent of myocardial repolarization
dispersion immediately following the shock (either caused by the
shock in case of VF induction, or due to lack of synchronization by
the shock in case of VF termination failure). Our intent was
directed purely at the mechanistic aspects of VF induction and
termination, and to demonstrate and extend for the human heart
data derived from our earlier experimental studies (3,4), namely,
that induction of functional reentry (i.e., VF) is facilitated by
dispersion of repolarization with its attendant dispersion of refrac-
toriness. Preshock dispersion is an important ingredient for post-
shock dispersion to manifest itself (2), but it was beyond the scope
of our study to analyze the multitude of factors that might have
influenced the former.
Michael R. Franz, MD, PhD
Cardiology Division
VAMC
50 Irving Street, NW
Washington, DC 20422
PII S0735-1097(00)01075-5
REFERENCES
1. Franz MR, Zabel M. Electrophysiological basis of QT dispersion
measurements. Prog Cardiovasc Dis 2000;42:311–24.
2. Zabel M, Klingenheben T, Franz MR, Hohnloser SH. Assessment of
QT dispersion for prediction of mortality or arrhythmic events after
myocardial infarction: results of a prospective, long-term follow-up
study. Circulation 1998;97:2543–50.
3. Behrens S, Li C, Fabritz CL, Kirchhof PF, Franz MR. Shock-induced
dispersion of ventricular repolarization: implications for the induction of
ventricular fibrillation and the upper limit of vulnerability. J Cardiovasc
Electrophysiol 1997;8:998–1008.
4. Fabritz CL, Kirchhof PF, Behrens S, Zabel M, Franz MR. Myocardial
vulnerability to T-wave shocks: relation to shock strength, shock
coupling interval, and dispersion of ventricular repolarization. J Cardio-
vasc Electrophysiol 1996;7:231–42.
C-Type Natriuretic
Peptide and Vascular Remodeling
Morishige et al. (1) have reported local adenovirus-mediated
transfer of C-type natriuretic peptide (CNP) to porcine coronary
arteries, resulting in reduced stenosis of balloon-injured segments.
This is an exciting development with obvious therapeutic poten-
tial. The investigators suggest several mechanisms by which CNP
might regulate vascular remodeling, but they fail to mention the
effects of CNP on the vascular renin-angiotensin system. Many
studies have demonstrated that the natriuretic peptides have a
tonic effect at various sites in the renin-angiotensin-aldosterone
cascade (2), and we have demonstrated that CNP inhibits local
conversion of angiotensin I to angiotensin II in the human forearm
vasculature (3). These vascular effects of CNP in man in vivo are
particularly relevant to the therapeutic potential of the technique
described by Morishige, because of the known interspecies vari-
ability in the effects of the natriuretic peptides (2). The effects of
angiotensin II on vascular remodeling are well-documented, and a
reduction in local angiotensin II production is a potentially
important mechanism for some of the observed effects of CNP.
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REPLY
We are grateful for the opportunity to respond to the valuable
comments by Drs. Davidson and Struthers concerning our recent
article in the Journal (1). In our article, we showed that adenovirus-
mediated overexpression of C-type natriuretic peptide (CNP) in
the porcine coronary artery suppresses vascular constrictive remod-
eling after balloon injury in vivo. However, as the authors pointed
out, we did not mention the possible effect of CNP on the
renin-angiotensin-aldosterone system, mainly because we did not
specifically examine this system in our study.
It is indeed possible that CNP/cGMP cascade may suppress the
vascular remodeling through various mechanisms, including
smooth muscle relaxation and inhibition of proliferation and
migration of smooth muscle cells and subsequent extracellular
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matrix deposition. Vascular remodeling appears to be caused by
complicated processes, in which the renin-angiotensin-aldosterone
system is involved. In this sense, we fully agree with Drs. Davidson
and Struthers that CNP should be regarded as an endogenous
regulator of the vascular renin-angiotensin-aldosterone system (2).
In our porcine model of inflammatory coronary arteriosclerosis,
which is characterized by constrictive remodeling and neointimal
formation, a complex cytokine network appears to be involved,
including several growth factors and inflammatory cytokines (3).
Furthermore, recent studies suggested that other mechanisms,
such as endothelial dysfunction, collagen accumulation, and
matrix-metalloproteinase activity, may also be involved in the
pathogenesis of vascular remodeling (4,5). We have recently
demonstrated that small GTP binding protein Rho and its target
Rho-kinase play an important role in the molecular mechanism of
vascular hyperreactivity as well as vascular remodeling in our
porcine model (6,7). Importantly, the Rho/Rho-kinase pathway is
involved in the cardiovascular effects of angiotensin II (8).
Taken together, it is highly possible in our study that the
inhibitory effect of CNP on the development of vascular remod-
eling was mediated, at least in part, by its modulatory effect on the
vascular renin-angiotensin-aldoesterone system. However, it re-
mains to be examined whether adenovirus-mediated overexpres-
sion of CNP in the coronary artery actually reduces the local
production of angiotensin II in our porcine model in vivo.
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Stress Testing and Electron
Beam Computed Tomography
for Evaluation of Patients With
Suspected Coronary Artery Disease
I read with interest the study by Shavelle et al. (1) on the value of
exercise testing and electron beam computed tomography (EBCT)
in the evaluation of coronary artery disease (CAD). The investi-
gators report that when applied to a population referred for
angiography, EBCT has a sensitivity of 96% and a specificity of
47% for detection of significant CAD (defined as $50% diameter
stenosis), and they conclude that “Electron beam computed to-
mography has a higher diagnostic ability than either treadmill
ECG or technetium-stress for the detection of obstructive angio-
graphic CAD.” They also suggest that a combination of EBCT
(for optimal sensitivity) with ECG stress testing (for improved
specificity and functional information) might be the preferred
approach for evaluating patients with suspected CAD.
Both these conclusions have to be viewed with skepticism: The
sensitivity of nuclear stress testing in their study (78%) is low,
almost equal to that of treadmill ECG (76%). When a broader
definition of “positive scan results” was used (either fixed or
reversible perfusion defects), the sensitivity was even lower (75%).
Other than a typographic error, I can see no explanation to this
paradox. Several studies have demonstrated that nuclear stress
testing has a significantly higher sensitivity for detection of CAD
than hereby presented. Even in the meta-analysis that the inves-
tigators quote (2), an almost 10% higher sensitivity (87%) was
reported, despite the inclusion of several older studies and some
with a stricter definition of “significant CAD” ($70% diameter
stenosis).
The investigators identify a number of reasons that could
explain the lower than expected specificity of nuclear testing in
their study, including the absence of ECG-gating and the high
likelihood of attenuation-induced defects. However, the low sen-
sitivity in the study is not adequately explained: If both fixed and
reversible defects were considered as abnormal, the underestima-
tion of reversibility that the authors quote (3,4) (and which has
been described for assessment of myocardial viability) should not
underestimate the sensitivity for detection of CAD. Moreover, the
potential Tc-99m redistribution that the researchers consider as a
source of decreased test sensitivity is minimal (3,5), if any at all
(6,7), and is unlikely to completely normalize significant perfusion
defects. In any case, the reference that Shavelle et al. quote (8) to
support their contention that redistribution might account for their
low Tc-99m stress test sensitivity does not address this issue.
Finally, the combined assessment of EBCT and treadmill ECG
should be evaluated with caution. In the Shavelle et al. study, 27
patients with a positive EBCT scan, one third of all positive
EBCT scans, were considered as having a negative “test.” What
was the severity of coronary calcification in these patients? Should
not the extent of calcification also be taken into account, if a
combined test approach were to be used?
The utility of EBCT as a research tool is unquestionable.
However, the clinical utility of EBCT, and for that matter any
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